当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 现金流量表

润达医疗

(603108)

  

流通市值:58.04亿  总市值:58.04亿
流通股本:6.05亿   总股本:6.05亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,583,514,349.161,771,453,008.628,428,657,472.686,241,287,710.63
  收到的税费返还9,680,806.594,623,517.112,128,631.698,813,577.04
  收到其他与经营活动有关的现金91,744,195.5348,058,112.74115,995,060.8487,228,428.74
  经营活动现金流入小计3,684,939,351.281,824,134,638.468,556,781,165.216,337,329,716.41
  购买商品、接受劳务支付的现金2,628,611,528.111,408,094,791.746,126,277,018.844,534,865,275.99
  支付给职工以及为职工支付的现金339,409,769.19174,393,116.24701,383,374.7542,047,242.01
  支付的各项税费170,307,657.7974,933,782.62362,760,277.05281,943,483.62
  支付其他与经营活动有关的现金273,326,424.53120,534,205.83729,138,283.85539,529,562.86
  经营活动现金流出小计3,411,655,379.621,777,955,896.437,919,558,954.445,898,385,564.48
  经营活动产生的现金流量净额273,283,971.6646,178,742.03637,222,210.77438,944,151.93
二、投资活动产生的现金流量:
  收回投资收到的现金289,900,000141,800,000497,040,000292,390,000
  取得投资收益收到的现金27,029,975.95437,469.9655,080,960.5854,214,972.54
  处置固定资产、无形资产和其他长期资产收回的现金净额3,671,368.291,062,740.6317,818,283.6211,636,630.15
  收到的其他与投资活动有关的现金66,689,125.49954,841.131,500,5501,500,550
  投资活动现金流入小计387,290,469.73144,255,051.72571,439,794.2359,742,152.69
  购建固定资产、无形资产和其他长期资产支付的现金86,135,276.6239,102,091.85250,484,597.64134,130,639.34
  投资支付的现金251,116,130.15131,916,130.15559,775,708.93368,103,353.15
  支付其他与投资活动有关的现金96,665,523.3996,642,201.19643,594.97430,410.63
  投资活动现金流出小计433,916,930.16267,660,423.19810,903,901.54502,664,403.12
  投资活动产生的现金流量净额-46,626,460.43-123,405,371.47-239,464,107.34-142,922,250.43
三、筹资活动产生的现金流量:
  吸收投资收到的现金400,000-154,285.71154,285.71
  其中:子公司吸收少数股东投资收到的现金400,000-154,285.71154,285.71
  取得借款收到的现金4,190,024,642.192,064,673,791.57,579,526,469.125,504,120,782.52
  收到其他与筹资活动有关的现金331,015,497200,515,497402,248,095362,930,000
  筹资活动现金流入小计4,521,440,139.192,265,189,288.57,981,928,849.835,867,205,068.23
  偿还债务支付的现金4,489,363,093.912,106,820,591.957,685,740,098.45,695,076,556.67
  分配股利、利润或偿付利息支付的现金193,102,078.0592,481,401.55420,996,611.98326,355,295.33
  其中:子公司支付给少数股东的股利、利润66,193,605.2641,411,805.26139,647,221.05106,180,000
  支付其他与筹资活动有关的现金342,961,631.27165,856,279.81494,596,421.9338,469,552.17
  筹资活动现金流出小计5,025,426,803.232,365,158,273.318,601,333,132.286,359,901,404.17
  筹资活动产生的现金流量净额-503,986,664.04-99,968,984.81-619,404,282.45-492,696,335.94
四、汇率变动对现金及现金等价物的影响-1,289,220.89-587,367.3-319,395.78226,848.1
五、现金及现金等价物净增加额-278,618,373.7-177,782,981.55-221,965,574.8-196,447,586.34
  加:期初现金及现金等价物余额667,045,710.31667,045,710.31889,011,285.11889,011,285.11
  期末现金及现金等价物余额388,427,336.61489,262,728.76667,045,710.31692,563,698.77
补充资料:
  净利润-61,421,266.16--518,150,880.46-
  资产减值准备913,179.76-208,737,137.88-
  固定资产和投资性房地产折旧143,619,209.5-286,439,547.75-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧143,619,209.5-286,439,547.75-
  无形资产摊销11,843,068.04-21,910,565.24-
  长期待摊费用摊销13,679,337.95-28,163,963.57-
  处置固定资产、无形资产和其他长期资产的损失2,146,048.92--3,119,148.21-
  固定资产报废损失4,083,045.82-3,571,120.88-
  财务费用138,991,477.19-279,777,407.24-
  投资损失-24,478,851.52--20,792,097.98-
  递延所得税-13,544,877.41--56,595,188-
  其中:递延所得税资产减少-6,755,759.27--56,818,983.7-
    递延所得税负债增加-6,789,118.14-223,795.7-
  存货的减少75,122,237.03--521,072,010.81-
  经营性应收项目的减少-342,250,500.4--70,246,852.02-
  经营性应付项目的增加208,473,301.05-748,943,020-
  现金的期末余额388,427,336.61-667,045,710.31-
  减:现金的期初余额667,045,710.31-889,011,285.11-
  现金及现金等价物的净增加额-278,618,373.7--221,965,574.8-
公告日期2026-08-282026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑